ArticlePharmaceuticals (Basel, Switzerland)2022

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases.

Stefania Chiappini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.